NCT02831387View on ClinicalTrials.gov

Evaluation of P-321 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease

PHASE2TerminatedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

July 31, 2016

Primary Completion Date

June 30, 2017

Study Completion Date

June 30, 2017

Conditions
Dry Eye Disease
Interventions
DRUG

P-321 Ophthalmic Solution

P-321 Ophthalmic Solution 0.017%

DRUG

P-321 Ophthalmic Solution placebo

Placebo to match P-321 Ophthalmic Solution

Trial Locations (7)

23502

Virginia Eye Consultants, Norfolk

27517

UNC Kittner Eye Center, Chapel Hill

63090

Comprehensive Eye Care, Ltd., Washington

63131

Ophthalmology Associates, St Louis

64111

Tauber Eye Center, Kansas City

77030

Ocular Surface Center, Baylor College of Medicine, Houston

90701

Sall Research Medical Center, Artesia

Sponsors

Lead Sponsor

Parion Sciences
All Listed Sponsors
lead

Parion Sciences

INDUSTRY

NCT02831387 - Evaluation of P-321 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease | Biotech Hunter | Biotech Hunter